Home › Gilead's $1,000-a-pill hepatitis C drug may make financial sense for prisons
 

Keywords :   


Gilead's $1,000-a-pill hepatitis C drug may make financial sense for prisons

2014-10-21 15:36:50| Biotech - Topix.net

Sovaldi's $1,000-a-pill price has grabbed headlines, but a new study suggests it may actually be cost effective for prison systems. Pricey new hepatitis C drugs, such as Gilead Sciences Inc.'s Sovaldi, may make financial sense to give to give to prisoners, one of the main groups infected with the liver-damaging virus, according to a team of Stanford University researchers.

Tags: make financial sense drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.09TSB customers hit by payment problems
24.09Potential Tropical Cyclone Nine Potential Storm Surge Flooding Map
24.09Potential Tropical Cyclone Nine Probabilistic Storm Surge Graphics
24.09Freudenberg Expands Coated Textiles Business
24.09Potential Tropical Cyclone Nine Graphics
24.09Potential Tropical Cyclone Nine Storm Surge Watch/Warning Map
24.09Farm Progress America, September 24, 2024
24.09Farm Progress America, September 24, 2024
More »